Literature DB >> 25478457

Effect of periodontal therapy on salivary interleukin-12 levels in chronic periodontitis.

Anamika Sharma1, B P Khattak2, S Naagtilak3, Ganesh Singh4, Tanveer Bano5.   

Abstract

BACKGROUND: Interleukin-12 (IL-12) is considered a central regulator of host resistance against a variety of pathogens. The influence of scaling and root planing was evaluated on amount of IL-12 in salivary fluid of patients with chronic generalized severe periodontitis, in relation to clinical parameters.
MATERIALS AND METHODS: A total of 50 subjects were enrolled, of which 25 had chronic generalized severe periodontitis, and 25 periodontally healthy as control. The clinical parameters included plaque index (PI), gingival index (GI), pocket probing depth (PPD) bleeding on probing (BOP) and clinical attachment loss (CAL). The level of IL-12 in salivary fluid was measured by ELISA kit at baseline and at four week following scaling and root planing.
RESULTS: Mean IL-12 levels in patients with periodontitis at baseline (9.79 ± 5.70 pg/ml) were higher than in controls (9.18±4.94 pg/ml; p=0.54.) Scaling and root planing resulted in significant increase in IL-12 levels (mean: 15.93±12.09 pg/ml; p =0.001) (control vs postoperative p <0.001). No significant correlations were found between IL-12 levels and any of the above clinical parameters.
CONCLUSION: Short-term nonsurgical therapy resulted in a significant improvement in periodontal indices and a marked increase in IL-12 levels.

Entities:  

Keywords:  Biomarkers; Chronic perioodontitis; Cytokines; Interleukin-12; Saliva

Year:  2014        PMID: 25478457      PMCID: PMC4253275          DOI: 10.7860/JCDR/2014/10598.5073

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  24 in total

Review 1.  Potential for gingival crevice fluid measures as predictors of risk for periodontal diseases.

Authors:  Catherine M E Champagne; William Buchanan; Michael S Reddy; John S Preisser; James D Beck; Steven Offenbacher
Journal:  Periodontol 2000       Date:  2003       Impact factor: 7.589

2.  PERIODONTAL DISEASE IN PREGNANCY. II. CORRELATION BETWEEN ORAL HYGIENE AND PERIODONTAL CONDTION.

Authors:  J SILNESS; H LOE
Journal:  Acta Odontol Scand       Date:  1964-02       Impact factor: 2.331

3.  The effect of SRP on the clinical and microbiological parameters of periodontal diseases.

Authors:  A D Haffajee; M A Cugini; S Dibart; C Smith; R L Kent; S S Socransky
Journal:  J Clin Periodontol       Date:  1997-05       Impact factor: 8.728

4.  Interleukin-1beta, interleukin-12 and interleukin-18 levels in gingival fluid and serum of patients with gingivitis and periodontitis.

Authors:  A Orozco; E Gemmell; M Bickel; G J Seymour
Journal:  Oral Microbiol Immunol       Date:  2006-08

5.  Steroid hormone analysis in human saliva.

Authors:  D O Quissell
Journal:  Ann N Y Acad Sci       Date:  1993-09-20       Impact factor: 5.691

6.  Interleukin-11, interleukin-1beta, interleukin-12 and the pathogenesis of inflammatory periodontal diseases.

Authors:  Ozlem Ozer Yücel; Ezel Berker; Semra Gariboğlu; Harika Otlu
Journal:  J Clin Periodontol       Date:  2008-05       Impact factor: 8.728

Review 7.  The immunopathogenesis of periodontal disease.

Authors:  E J Ohlrich; M P Cullinan; G J Seymour
Journal:  Aust Dent J       Date:  2009-09       Impact factor: 2.291

8.  Immunohistological identification of cell subsets in human gingiva after local treatment for gingivitis or periodontitis.

Authors:  J M Jully; M C Béné; G Martin; G Faure
Journal:  J Clin Periodontol       Date:  1986-03       Impact factor: 8.728

Review 9.  Interleukin-12 and the regulation of innate resistance and adaptive immunity.

Authors:  Giorgio Trinchieri
Journal:  Nat Rev Immunol       Date:  2003-02       Impact factor: 53.106

10.  Effect of periodontal therapy on crevicular fluid interleukin-6 and interleukin-8 levels in chronic periodontitis.

Authors:  Paschalina Goutoudi; Evdoxia Diza; Malamatenia Arvanitidou
Journal:  Int J Dent       Date:  2011-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.